As of November 2026 Latigo Biotherapeutics has a market cap of A$1.38 Billion. This makes Latigo Biotherapeutics the world's 6313th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 2nd, 2026 the market cap of Latigo Biotherapeutics was reported to be: